Background: Patients with terminal cancer frequently suffer from sleep sweats, which occur while sleeping and cease after waking; the cause of these sweats is unknown. The aim of this study was to evaluate the efficacy of a modified Dang Gui Liu Huang Tang in managing sleep sweats, as well as to identify any associated adverse effects. Methods: We enrolled 41 patients with terminal cancer who were receiving hospice care. We excluded patients whose sweating had known causes, as well as those taking drugs that can affect the sweating threshold. Patients received a modified Dang Gui Liu Huang Tang twice a day for 10 consecutive days. Results: The quantitative assessment revealed that sleep sweating was completely relieved in 29 (70.7%) patients, and that the average time required for a 50% decrease in sweating was 5.3 days. Using a visual analog sweating scale that ranged from 0 to 10, patients and caregivers estimated that the mean decrease in sweating was 7.6 and 8.0, respectively. Furthermore, 78.0% of patients experienced an increased appetite after treatment. The most common adverse events were diarrhea (14.6%), nausea (12.1%), and allergy (2.4%), although the severity of these symptoms was never greater than Grade 2, and they resolved after the treatment was stopped. Conclusion: The results suggest that the modified Dang Gui Liu Huang Tang is safe and effective in treating sleep sweats of an unknown cause in elderly patients with terminal cancer.
Introduction
Traditional herbal medicine is widely accepted and commonly used by Asians because of its safety, natural origin, and fewer adverse effects. Epidemiological surveys have shown that 44.6% of patients with cancer in Japan, and 31.4% in the USA, took complementary medicine during or after major cancer treatments 1,2 .
Cancer is the leading cause of death in many countries; at its terminal stage, patients suffer from various complications, which often develop simultaneously 3e5 . The majority of these complications can be alleviated or eased using palliative medicines. However, several troublesome symptoms have no specific and effective treatment; sweating is one such symptom. Patients with terminal cancer often suffer from frequent sweating of unknown cause. For example, sleep sweats, which are characterized by sweating that develops while sleeping and ceases after waking, are particularly common in immunocompromised cancer patients. Such sweats usually render patients more susceptible to upper airway infections and resulting sepsis.
In traditional Chinese medicine (TCM), several effective herbal prescriptions are available for treating sleep sweats; these prescriptions are based on the different treatment principles used in TCM. The most commonly prescribed herbal medication for sleep sweats is Dang Gui Liu Huang Tang. This decoction functions to nourish "Yin", clear heat, and stabilize the exterior while stopping sweating. Some other symptoms that indicate Dang Gui Liu Huang Tang are fever, red face, dry mouth, dry parched lips, irritability, dry stools, constipation, and scanty dark urine. In addition, as confirmed by clinical observations, Fu Xiao Mai (Tritici levis fructus) and Mu Li (Ostreae concha) are also widely used to treat sweating. Therefore, we combined these two herbal drugs with Dang Gui Liu Huang Tang to form a modified prescription; we then evaluated the prescription's effectiveness. To our knowledge, no clinical evidence supports the use of this modified regimen to treat sleep sweats.
In the present study, we evaluated the efficacy of our modified Dang Gui Liu Huang Tang in treating sleep sweats, as well as the adverse events associated with the treatment. The study involved patients with terminal cancer who were receiving palliative care in a medical center-based hospice ward.
Materials and methods

Participants
Between January 2000 and February 2003, 41 biopsy-confirmed patients with cancer who were suffering from sleep sweats were enrolled in this prospective study. The other eligibility criteria were age > 60 years, ability to tolerate oral or nasogastric tube feeding, and receipt of palliative care in a medical center-based hospice ward. The exclusion criteria were as follows: fever > 37.5 C (aural), hypoglycemia, use of drugs that can affect the sweating temperature threshold (clonidine, pilocarpine, physostigmine, atropine, scopolamine, tramadol, or oral contraceptives), and bowel obstruction. The study was approved by the Institutional Review Board of the Mackay Memorial Hospital, Taipei, Taiwan (IRB Number: 13MMHIS050), and informed consent was obtained from all study participants.
Treatment regimen and protocol
Dang Gui Liu Huang Tang is a traditional therapy comprising drugs prepared from seven medicinal plants: Dang Gui (Radix Angelicae sinensis), Sheng Di Huang (Epimedium sagittatum), Shu Di Huang (E. sagittatum), Huang Qin (Radix Scutellariae baicalensis), Huang Lian (Rhizoma Coptidis), Huang Bai (Cortex Phellodendri), and Huang Qi (Radix Astragali). In our study, we modified Dang Gui Liu Huang Tang by adding two further herbal drugs that are widely used to treat sweating: Fu Xiao Mai (Tritici levis fructus) and Mu Li (Ostreae concha). The daily dose of the modified Dang Gui Liu Huang Tang was 9.0 g Dang Gui, 15.0 g Sheng Di Huang, 12.0 g Shu Di Huang, 9.0 g Huang Qin, 8.0 g Huang Lian, 8.0 g Huang Bai, 15.0 g Huang Qi, 11.25 g Fu Xiao Mai, and 15.0 g Mu Li. The herbs were chopped, and their extracts were obtained twice a day using 1000 mL of boiling water until 200 mL of liquid remained in the container. Each 200 mL herb concentrate was administered to the enrolled patients after breakfast and dinner for 10 consecutive days; a 1-hour interval was followed between the administration of the extracts and that of other drugs. We attempted to complete the entire course of this herbal regimen; however, the treatment was discontinued in cases where allergy, bowel obstruction, disturbance to consciousness, or death rattle developed.
Quantitative assessment of sleep sweats
Sweating was measured using a paper tissue absorption method. Twice each daydat 9:00 AM and 9:00 PMd10 layers of cut paper tissues (2 cm Â 2 cm) were placed over an area of smooth skin on the right side of the neck (at the midpoint of the sternocleidomastoid muscle) and tightly covered using a 6 cm Â 7-cm Tegaderm dressing (3M Health Care Co., Minneapolis, MN, USA). The change in the weight of the paper tissue was calculated immediately after its removal; the same well-trained physician's assistant both applied and removed the tissue. This evaluation was performed daily, starting on the day before treatment initiation, until the 10 th day of treatment.
Subjective estimation of sweating
The overall change in sweating symptoms was estimated by the patients and their caregivers using a visual analog scale (VAS) that ranged from 0 to 10.
Safety assessment
Safety evaluations were graded according to Version 2 of the Common Toxicity Criteria, published by the National Cancer Institute in 1998 6 .
Data analysis
Data were expressed as mean ± standard error. Repeated measures analysis of variance was used to compare the amount of sweating with the subjective estimation of sweating over time. Statistical analyses were performed using the SPSS software package Version 18.0 (SPSS Inc., Chicago, IL, USA), and p < 0.05 was considered significant.
Results
The characteristics of the 41 patients are presented in Table 1 . In summary, the mean age of the study participants was 69.0 ± 6.4 
